Glutathione-mediated release of Bodipy® from PEG cofunctionalized gold nanoparticles

Dhiraj Kumar, Brian J Meenan, Dorian DixonNanotechnology and Integrated BioEngineering Centre, University of Ulster, Belfast, Northern IrelandAbstract: Gold nanoparticles synthesized via sodium citrate reduction of chloroauric acid (HAuCl4) were functionalized with either various concentrations of t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kumar D, Meenan BJ, Dixon D
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2012
Materias:
Acceso en línea:https://doaj.org/article/efb55746435d4e73911663cb6c6764c7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:efb55746435d4e73911663cb6c6764c7
record_format dspace
spelling oai:doaj.org-article:efb55746435d4e73911663cb6c6764c72021-12-02T11:10:53ZGlutathione-mediated release of Bodipy® from PEG cofunctionalized gold nanoparticles1176-91141178-2013https://doaj.org/article/efb55746435d4e73911663cb6c6764c72012-07-01T00:00:00Zhttp://www.dovepress.com/glutathione-mediated-release-of-bodipyreg-from-peg-cofunctionalized-go-a10509https://doaj.org/toc/1176-9114https://doaj.org/toc/1178-2013Dhiraj Kumar, Brian J Meenan, Dorian DixonNanotechnology and Integrated BioEngineering Centre, University of Ulster, Belfast, Northern IrelandAbstract: Gold nanoparticles synthesized via sodium citrate reduction of chloroauric acid (HAuCl4) were functionalized with either various concentrations of thiol-terminated Bodipy® FL L-cystine (0.5, 1.0, 1.5, and 2.0 µg/mL) or Bodipy-poly(ethylene glycol) at concentrations of 0.5–18.75, 1.0–12.50, and 1.5–6.25 µg/mL to form a mixed monolayer of BODIPY-PEG. Thiol-terminated Bodipy, a fluorescing molecule, was used as the model drug, while PEG is widely used in drug-delivery applications to shield nanoparticles from unwanted immune responses. Understanding the influence of PEG-capping on payload release is critical because it is the most widely used type of nanoparticle functionalization in drug delivery studies. It has been previously reported that glutathione can trigger release of thiol-bound payloads from gold nanoparticles. Bodipy release from Bodipy capped and from Bodipy-PEG functionalized gold nanoparticles was studied at typical intracellular glutathione levels. It was observed that the addition of PEG capping inhibits the initial burst release observed in gold nanoparticles functionalized only with Bodipy and inhibits nanoparticle aggregation. Efficient and controlled payload release was observed in gold nanoparticles cofunctionalized with only a limited amount of PEG, thus enabling the coattachment of large amounts of drug, targeting groups or other payloads.Keywords: gold nanoparticles, FL L-cystine, Bodipy®, poly(ethylene glycol), glutathione-mediated release, photoluminescenceKumar DMeenan BJDixon DDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2012, Iss default, Pp 4007-4022 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine (General)
R5-920
spellingShingle Medicine (General)
R5-920
Kumar D
Meenan BJ
Dixon D
Glutathione-mediated release of Bodipy® from PEG cofunctionalized gold nanoparticles
description Dhiraj Kumar, Brian J Meenan, Dorian DixonNanotechnology and Integrated BioEngineering Centre, University of Ulster, Belfast, Northern IrelandAbstract: Gold nanoparticles synthesized via sodium citrate reduction of chloroauric acid (HAuCl4) were functionalized with either various concentrations of thiol-terminated Bodipy® FL L-cystine (0.5, 1.0, 1.5, and 2.0 µg/mL) or Bodipy-poly(ethylene glycol) at concentrations of 0.5–18.75, 1.0–12.50, and 1.5–6.25 µg/mL to form a mixed monolayer of BODIPY-PEG. Thiol-terminated Bodipy, a fluorescing molecule, was used as the model drug, while PEG is widely used in drug-delivery applications to shield nanoparticles from unwanted immune responses. Understanding the influence of PEG-capping on payload release is critical because it is the most widely used type of nanoparticle functionalization in drug delivery studies. It has been previously reported that glutathione can trigger release of thiol-bound payloads from gold nanoparticles. Bodipy release from Bodipy capped and from Bodipy-PEG functionalized gold nanoparticles was studied at typical intracellular glutathione levels. It was observed that the addition of PEG capping inhibits the initial burst release observed in gold nanoparticles functionalized only with Bodipy and inhibits nanoparticle aggregation. Efficient and controlled payload release was observed in gold nanoparticles cofunctionalized with only a limited amount of PEG, thus enabling the coattachment of large amounts of drug, targeting groups or other payloads.Keywords: gold nanoparticles, FL L-cystine, Bodipy®, poly(ethylene glycol), glutathione-mediated release, photoluminescence
format article
author Kumar D
Meenan BJ
Dixon D
author_facet Kumar D
Meenan BJ
Dixon D
author_sort Kumar D
title Glutathione-mediated release of Bodipy® from PEG cofunctionalized gold nanoparticles
title_short Glutathione-mediated release of Bodipy® from PEG cofunctionalized gold nanoparticles
title_full Glutathione-mediated release of Bodipy® from PEG cofunctionalized gold nanoparticles
title_fullStr Glutathione-mediated release of Bodipy® from PEG cofunctionalized gold nanoparticles
title_full_unstemmed Glutathione-mediated release of Bodipy® from PEG cofunctionalized gold nanoparticles
title_sort glutathione-mediated release of bodipy® from peg cofunctionalized gold nanoparticles
publisher Dove Medical Press
publishDate 2012
url https://doaj.org/article/efb55746435d4e73911663cb6c6764c7
work_keys_str_mv AT kumard glutathionemediatedreleaseofbodipyampregfrompegcofunctionalizedgoldnanoparticles
AT meenanbj glutathionemediatedreleaseofbodipyampregfrompegcofunctionalizedgoldnanoparticles
AT dixond glutathionemediatedreleaseofbodipyampregfrompegcofunctionalizedgoldnanoparticles
_version_ 1718396206289256448